Why Is Zirgan So Hard to Find? [Explained for 2026]

You just got a prescription for Zirgan (ganciclovir ophthalmic gel) and your pharmacy doesn't have it. You call the next one — same story. If this sounds familiar, you're not alone. Zirgan is one of those specialty eye medications that isn't stocked on every pharmacy shelf, and tracking it down can feel like a full-time job when you're already dealing with a painful eye infection.

Let's break down exactly why Zirgan can be hard to find — and what you can do about it right now.

What Is Zirgan and Why Is It Prescribed?

Zirgan is the brand name for ganciclovir ophthalmic gel 0.15%, an antiviral medication used to treat acute herpetic keratitis — a painful corneal infection caused by the herpes simplex virus (HSV). It was FDA-approved in 2009 and is currently the only FDA-approved ophthalmic gel formulation of ganciclovir in the United States.

Herpetic keratitis isn't rare — herpes simplex virus eye infections affect roughly 500,000 Americans per year — but it's a niche enough condition that most general-use pharmacies don't keep Zirgan on their shelves at all times. That disconnect between a serious medical need and limited routine stocking is at the heart of why patients struggle to fill this prescription.

Why Is Zirgan Hard to Find at Pharmacies?

Several factors combine to make Zirgan consistently harder to stock than mainstream medications:

1. It's a Brand-Only Drug with No Generic

As of 2026, there is no FDA-approved generic version of Zirgan in the United States. When a drug exists only as a brand name, pharmacies face a higher purchase cost and greater financial risk from having inventory sit unsold. High-volume chain pharmacies tend to stock drugs they'll move quickly. A brand-name-only specialty ophthalmic gel in a 5-gram tube doesn't fit that profile at every location.

2. Low Overall Prescription Volume

Herpetic keratitis is primarily managed by ophthalmologists and optometrists — a more specialized prescriber base than, say, primary care doctors. Many pharmacies simply don't receive enough Zirgan prescriptions to justify keeping it in regular inventory. When a prescription does come in, the pharmacist may have to order it from a wholesaler, adding 24–72 hours to your wait time.

3. It Was Originally Granted Orphan Drug Status

The original manufacturer, Sirion Therapeutics, received orphan drug designation for Zirgan because herpetic keratitis, while not trivial, is classified as a rare disease under FDA standards. Orphan drug status signals niche demand, and niche demand means smaller supply chains and less widespread stocking.

4. It's a Specialty Ophthalmic Product

Ophthalmic gel formulations require specific storage conditions (15°C–25°C, never frozen) and are produced in small tubes (5 grams). Specialty ophthalmic products are often handled through specialty pharmacy networks rather than standard retail distributors. This limits which pharmacies can reliably stock Zirgan and fulfil prescriptions on demand.

Is There a Zirgan FDA Shortage?

As of 2026, Zirgan does not appear on the FDA's official Drug Shortage Database. This means the manufacturer (Bausch + Lomb) is not reporting a supply interruption, and the product is being manufactured. However, not being on the shortage list doesn't mean you'll find it at your corner pharmacy. Distribution gaps and low stocking levels mean patients routinely encounter empty shelves even when the drug technically exists in the supply chain.

What Should You Do If You Can't Find Zirgan?

Here's an action plan if your pharmacy is out of stock:

Call independent and specialty pharmacies. Independent pharmacies and eye care-focused pharmacies are more likely to stock Zirgan or be able to order it quickly.

Ask your ophthalmologist's office. Many ophthalmology practices keep Zirgan samples on hand or know which local pharmacies carry it.

Try specialty mail-order pharmacies. Specialty pharmacy networks often have better access to niche ophthalmic products like Zirgan.

Ask about alternatives. Trifluridine (generic Viroptic) is an older topical antiviral that treats the same condition and is more widely stocked. Oral antivirals like acyclovir or valacyclovir may also be options. Talk to your doctor before switching.

Use medfinder. medfinder calls pharmacies near you to find out which ones have Zirgan in stock, so you don't have to spend hours on the phone.

Is Zirgan Worth the Effort to Find?

For most patients with active herpetic keratitis, yes. Zirgan is selectively active in virus-infected cells and inactive in healthy corneal cells — a significant advantage over older agents like trifluridine, which can damage the ocular surface with prolonged use. Clinical trials showed 77% resolution of dendritic ulcers within 7 days, and its convenient dosing schedule (5 drops/day initially) makes it easier to comply with treatment.

That said, time matters when you have a corneal infection. The longer treatment is delayed, the greater the risk of corneal scarring. If you absolutely cannot find Zirgan in time, talk to your prescriber about starting on an oral antiviral (like acyclovir 400 mg five times daily) while you search.

How medfinder Can Help You Find Zirgan Near You

Instead of calling pharmacy after pharmacy, medfinder does the calling for you. You provide your medication, dosage, and location — medfinder contacts pharmacies in your area to find out who can fill your Zirgan prescription, then texts you the results. It saves you hours of frustration and gets you to treatment faster.

For more detailed tips on locating Zirgan near you, read our guide: How to Find Zirgan In Stock Near You (Tools + Tips). You can also explore our overview of Zirgan alternatives if your search proves unsuccessful.